HistologiX was formed in 2005 to provide quality Histology and Immunohistochemistry (IHC) Services and multi-site studies for the Pharmaceutical and Biotechnology industry. It was also our aim to provide human and animal tissue based solutions in support of regulatory preclinical programmes, clinical trials in addition to Biomarker development projects.
Initial GLP accreditation was obtained in November 2005 and retained by inspection in 2007 and retained until recent inspections in 2016. HistologiX is also licensed by the Human Tissue Authority (HTA) to source and store human tissue and has ethical approval to undertake antibody screening in human tissues and boasts customers in the UK, Europe, Scandanavia, Israel, South Africa, USA and Canada.
Histologix has taken the positive step through strategic agreements with external partners to bring to our clients services that include the sourcing of high quality normal and diseased human tissues, Toxicology, Pharmacology/PK, Tumour cell lines/xenograft efficacy studies, Biosimilar studies, clinical and veterinary trials. Our ability to support your drug programmes is now greatly enhanced by bringing together these service providers with niche areas of expertise to provide strong scientific solutions to your development issues.
Histologix continues to work with a range of clients that include some of the top pharmaceutical companies worldwide as well as small and medium but highly innovative biotechnology companies.
Histologix provides the Pharmaceutical and Biotechnology industry with specialist pathology services to assist drug development programmes ranging from Discovery, regulatory preclinical safety testing through to clinical trials and include human tissue sourcing, histology, medical and veterinary histopathology, immunohistochemistry, digital pathology and image analysis. These are technologies that have been developed with to meet current and future requirements of targeted therapy.
Through inward investment the services provided by Histologix Ltd use a range of highly sophisticated technologies and platforms aimed at standardising the various processes involved in order to achieve data generation that is consistent, accurate and reproducible and will assist our clients in the development of their drug programmes.
Histologix is a privately owned contract research organisation that provides specialist pathology services for the Pharmaceutical and Biotechnology industry. Set up in 2005 by industry specialists, Histologix is a GLP/GCP accredited, HTA-licenced company with an extensive and impressive track record of successfully delivering a range of IHC/ISH assays to large and small Pharma/Biotechnology companies and is a preferred supplier of these services to a number of companies.
Find out which conference Histologix is exhibiting at, updated news issues and current vacancies.